Mesenchymal stromal cells can be derived from bone marrow CD133 + cells: Implications for therapy

Stem Cells and Development

Volumn 18, Issue 3, 2009, Pages 497-509

  Pozzobon, Michela ^a   Piccoli, Martina ^a   Ditadi, Andrea ^a   Bollini, Sveva ^a   Destro, Roberta ^a   André Schmutz, Isabelle ^b   Masiero, Laura ^a   Lenzini, Elisabetta ^a   Zanesco, Luigi ^a   Petrelli, Lucia ^a   Cavazzana Calvo, Marina ^c   Gazzola, Maria Vittoria ^a   De Coppi, Paolo ^a,d  

^a UNIVERSITY OF PADOVA   (Italy)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; STEM CELL FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; ECTODERM; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MESODERM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; GLYCOPROTEINS; HUMANS; KARYOTYPING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MOLECULAR SEQUENCE DATA; PEPTIDES; STROMAL CELLS; TISSUE THERAPY;

EID: 65349157688     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0003     Document Type: Article

References (56)

1. Horwitz EM, PL Gordon, WK Koo, JC Marx, MD Neel, RYMcNall, L Muul and T Hofmann. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99(13):8932-8937.
2. Koc ON, SL Gerson, BW Cooper, SM Dyhouse, SE Haynesworth, AI Caplan and HM Lazarus. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316.
3. Petite H, V Viateau, W Bensaïd, A Meunier, C de Pollak, M Bourguignon, K Oudina, L Sedel and G Guillemin. (2000). Tissue-engineered bone regeneration. Nat Biotechnol 18:959-963.
4. Gang EJ, D Bosnakovski, CA Figueiredo, JW Visser and RC Perlingeiro. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751.
5. Martinez C, TJ Hofmann, R Marino, M Dominaci and EM Horwitz. (2007). Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 109:4245-4248.
6. D'Ippolito G, S Diabira, GA Howard, P Menei, BA Roos and PC Schiller. (2004). Marrow-isolated adult multilineage induc-ible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971-2981.
7. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2007). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
8. Fargeas CA, WB Huttner and D Corbeil. (2007). Nomenclature of prominin-1 (CD133) splice variants - an update. Tissue Antigens 69:602-606.
9. Yin AH, S Miraglia, ED Zanjani, G Almeida-Porada, M Ogawa, AG Leary, J Olweus, J Kearney and DW Buck. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012.
10. Timmermans F, F Van Hauwermeiren, M De Smedt, R Raedt, F Plasschaert, ML De Buyzere, TC Gillebert, J Plum and B Vandekerckhove. (2007). Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 27:1572-1579.
11. López-Holgado N, M Alberca, F Sánchez-Guijo, E Villarón, J Almeida, A Martín, A Armellini, C García, B Blanco, I Sánchez-Abarca, S Martín, JA Pérez-Simón, R García-Sanz, JF San Miguel and MC del Cañizo. (2007). Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy 9:14-22.
12. Peichev M, AJ Naiyer, D Pereira, Z Zhu, WJ Lane, M Williams, MC Oz, DJ Hicklin, L Witte, MA Moore and S Rafii. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958.
13. Lang P, P Bader, M Schumm, T Feuchtinger, H Einsele, M Führer, C Weinstock, R Handgretinger, S Kuci, D Martin, D Niethammer and J Greil. (2004). Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br J Haematol. 124(1), 72-79.
14. Koehl U, S Zimmermann, R Esser, J Sörensen, HP Grüttner, M Duchscherer, E Seifried, T Klingebiel and D Schwabe. (2002). Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia. Bone Marrow Transplant 29:927-930.
15. Stamm C, B Westphal, HD Kleine, M Petzsch, C Kittner, H Klinge, C Schümichen, CA Nienaber, M Freund and G Steinhoff. (2003). Autologous bone-marrow stem-cell transplantation for myocar-dial regeneration. Lancet 361:45-46.
16. Torrente Y, M Belicchi, M Sampaolesi, F Pisati, M Meregalli, G D'Antona, R Tonlorenzi, L Porretti, M Gavina, K Mamchaoui, MA Pelligrino, D Furling, V Mouly, GS Butler-Browne, R Bottinelli, G Cossu and N Bresolin. (2004). Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114:182-195.
17. Masiero L, MV Gazzola, R Destro, C Messina, M Piccoli, F Castello, GF Zanon, PG Gamba, L Zanesco and P De Coppi. (2004). Biology and plasticity of BM- and UC blood-derived human CD133+ stem cell: a promising source for clinical application. ISSN 1: abstract P18.
18. Tondreau T, N Meuleman, A Delforge, M Dejeneffe, R Leroy, M Massy, C Mortier, D Bron and L Lagneaux. (2005). Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23:1105-1112.
19. Reyes M, T Lund, T Lenvik, D Aguiar, LKoodie and CM Verfaillie. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625.
20. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
21. De Coppi P, M Pozzobon, M Piccoli, MV Gazzola, L Boldrin, E Slanzi, R Destro, L Zanesco, GF Zanon and P Gamba. (2006). Isolation of mesenchymal stem cells from human vermiform appendix. J Surg Res 135:85-91.
22. Back E, R Toder, I Voiculescu, A Wildberg and W Schempp. (1994). De novo isochromosome 18p in two patients: cytogenetic diagnosis and confirmation by chromosome painting. Clin Genet 45:301-304. Review.
23. Freund D, J Oswald, S Feldmann, G Ehninger, D Corbeil and M Bornhäuser. (2006). Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor. Cell Prolif 39:325-332.
24. Bhatia M, D Bonnet, B Murdoch, OI Gan and JE Dick. (1998). A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4:1038-1045.
25. Sharkis SJ, MI Collector, JP Barber, MS Vala and RJ Jones. (1997). Phenotypic and functional characterization of the hematopoietic stem cell. Stem Cells 15(Suppl 1):41-44.
26. Pittenger M, P Vanguri, D Simonetti and R Young. (2002). Adult mesenchymal stem cells: potential for muscle and tendon regeneration and use in gene therapy. J Musculoskelet Neuronal Interact 2:309-320.
27. Digirolamo CM, D Stokes, D Colter, DG Phinney, R Class and DJ Prockop. (1999). Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281.
28. Leontiadis E, A Manginas and DV Cokkinos. (2006). Cardiac repair - fact or fancy? Heart Fail Rev 11:155-70. Review.
29. Zimmermann S, M Voss, S Kaiser, U Kapp, CF Waller and UM Martens. (2003). Lack of telomerase activity in human mes-enchymal stem cells. Leukemia 17:1146-1149.
30. Hiyama E and K Hiyama. (2007). Telomere and telomerase in stem cells. Br J Cancer 96:1020-4. Review.
31. Quirici N, D Soligo, P Bossolasco, F Servida, C Lumini and GL Deliliers. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783-791.
32. Hofmann WK, S de Vos, M Komor, D Hoelzer, W Wachsman and HP Koeffler. (2002). Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 100:3553-3360.
33. Jones EA, SE Kinsey, A English, RA Jones, L Straszynski, DM Meredith, AF Markham, A Jack, P Emery and D McGonagle. (2002). Isolation and characterization of bone marrow mul-tipotential mesenchymal progenitor cells. Arthritis Rheum 46:3349-3360.
34. Handgretinger R, PR Gordon, T Leimig, X Chen, HJ Buhring, D Niethammer and S Kuci. (2003). Biology and plasticity of CD133+ hematopoietic stem cells. Ann N Y Acad Sci 996:141-151.
35. Kuçi S, JT Wessels, HJ Bühring, K Schilbach, M Schumm, G Seitz, J Löffler, P Bader, PG Schlegel, D Niethammer and R Handgretinger. (2003). Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. Blood 101:869-876.
36. Forraz N, R Pettengell and CP McGuckin. (2004). Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells 22:100-108.
37. Kögler G, S Sensken, JA Airey, T Trapp, M Müschen, N Feldhahn, S Liedtke, RV Sorg, J Fischer, C Rosenbaum, S Greschat, A Knipper, J Bender, O Degistirici, J Gao, AI Caplan, EJ Colletti, G Almeida-Porada, HW Müller, E Zanjani and P Wernet. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135.
38. Huss R. (2000). Isolation of primary and immortalized CD34-hematopoietic and mesenchymal stem cells from various sources. Stem Cells 18:1-9. Review.
39. Pomyje J, J Zivny, L Sefc, M Plasilova, R Pytlik and E Necas. (2003). Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells. Eur JHaematol 70:143-150.
40. Oswald J, S Boxberger, B Jørgensen, S Feldmann, G Ehninger, M Bornhäuser and C Werner. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377-384.
41. Friedrich EB, K Walenta, J Scharlau, G Nickenig and N Werner. (2006). CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98:20-25.
42. Hilbe W, S Dirnhofer, F Oberwasserlechner, T Schmid, E Gunsilius, G Hilbe, E Woll, and CM Kahler. (2004). CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57:965-969.
43. Sussman LK, JN Upalakalin, MJ Roberts, O Kocher and Benjamin L. (2003). Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol Ther 2:255-256.
44. Salven P, S Mustjoki, R Alitalo, K Alitalo and S Rafii. (2003). VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101:168-172.
45. Nomi M, A Atala, P De Coppi and S Soker. (2002). Principals of neovascularization for tissue engineering. Mol Aspects Med 23:463-483. Review.
46. Wang R, RA Clark, DF Mosher and XD Ren. (2000). Fibronectin's central cell-binding domain supports focal adhesion formation and Rho signal transduction. J Biol Chem 280:28803-28810.
47. Miyamoto S, BZ Katz, RM Lafrenie and KM Yamada. (1998). Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann N Y Acad Sci 857:119-129. Review.
48. Suuronen EJ, S Wong, V Kapila, G Waghray, SC Whitman, TG Mesana and M Ruel. (2006). Generation of CD133+ cells from CD133- peripheral blood mononuclear cells and their properties. Cardiovasc Res 70:126-135.
49. Gregory CA, DJ Prockop and JL Spees. (2005). Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res 306:330-5.
50. In't Anker PS, WA Noort, SA Scherjon, C Kleijburg-van der Keur, AB Kruisselbrink, RL van Bezooijen, W Beekhuizen, R Willemze, HH Kanhai and WE Fibbe. (2003). Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845-852.
51. Urbich C and S Dimmeler. (2004). Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343-353.
52. Loges S, B Fehse, MA Brockmann, K Lamszus, M Butzal, M Guckenbiehl, G Schuch, S Ergün, U Fischer, AR Zander, DK Hossfeld, W Fiedler and UM Gehling. (2004). Identification of the adult human hemangioblast. Stem Cells Dev 13:229-242.
53. Pierelli L, G Scambia, G Bonanno, S Rutella, P Puggioni, A Battaglia, S Mozzetti, M Marone, G Menichella, C Rumi, S Mancuso and G Leone. (2000). CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursors. Br J Haematol 108:610-620.
54. Newman PJ. (1997). The biology of PECAM-1. J Clin Invest 100(11 Suppl):S25-29. Review.
55. Cho SK, A Bourdeau, M Letarte and JC Zuniga-Pflucker. (2001). Expression and function of CD105 during the onset of hemato-poiesis from Flk1(+) precursors. Blood 98:3635-3642.
56. Fibbe WE and WA Noort. (2003). Mesenchymal stem cells and hematopoietic stem cell transplantation. Ann N Y Acad Sci 996:235-244.